Harvard technology to be commercialized by Vesigen Therapeutics

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.

Caroline Perry • harvard
July 22, 2020 • ~10 min

Major study on Duchenne muscular dystrophy gains support

Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.

Caroline Perry • harvard
Jan. 9, 2020 • ~6 min

/

1